Jevon Holland

Safety

Age: 25
Free Agency: 2028 (UFA)
Accrued Seasons: 4
  • 2025 Salary Cap Charge: $9,941,176 (3.43% of cap)
  • 2025 Cash Payout: $18,000,000 (6.74% of spending)
  • 2025 Cash to Cap Ratio: 1.81
  • Contract Value: $45,300,000 ($15,100,000 APY)
  • Fully Guaranteed Money: $27,400,000
  • Contract Ranking: 8/170 at S

Current Contract

(UFA, signed 2025)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202525$5,400,000$4,000,000$500,000$100,000$5,400,000$9,941,1763.4%
2026 📝
March 17: $2.9 million is guaranteed
26$12,900,000$4,000,000$500,000$100,000$10,000,000$17,500,0005.9%
202727$13,200,000$4,000,000$500,000$100,000$0$17,800,0005.7%
Total$31,500,000$12,000,000$1,500,000$300,000$15,400,000$45,241,176

Contract Notes

Jevon Holland signed a three year, $45.3 million contract with the Giants. $30.3 million is guaranteed of which $27.4 million is fully guaranteed at signing. Holland received a $12 million signing bonus and his 2025 salary is fully guaranteed. $10 million of his 2026 salary is fully guaranteed with another $2.9 million becoming fully guaranteed on the 3rd day of the 2026 league year. There are annual per game bonuses of $500,000 and workout bonuses of $100,000.

Cash Flows

- fully earned money
- unearned or partially earned money
$15.1M
$30.2M
$45.3M
202520262027
Cash Due$18,000,000$13,500,000$13,800,000
Running Cash$18,000,000$31,500,000$45,300,000
Career Earnings: $22,233,804
Career APY: $5,558,451
Potential Earnings: $55,533,804
Total Guarantees: $33,657,796
Largest Cash Payment: $18,000,000 (2025)
Largest Cap Number: $17,800,000 (2027)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
DolphinsDraftedExpired20214$8,716,404$2,179,101$6,257,796$10,233,804117.4%$2,558,451
GiantsUFAActive20253$45,300,000$15,100,000$27,400,000$12,000,00026.5%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Dolphins4$10,233,804$2,558,451$10,233,8040.0%$00.0%
Giants0$12,000,000$0$00.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2021Dolphins$660,000$924,801$0$0$660,000$1,584,8010.8%$4,359,204
2022Dolphins$1,056,200$924,801$0$0$1,056,201$1,981,0010.9%$1,056,200
2023Dolphins$1,452,402$924,801$0$0$842,392$2,377,2011.1%$1,452,400
2024Dolphins$3,366,000$924,801$0$0$0$4,290,8011.7%$3,366,000
2025Giants$5,400,000$4,000,000$500,000$100,000$5,400,000$9,941,1763.4%$18,000,000
2026Giants$12,900,000$4,000,000$500,000$100,000$10,000,000$17,500,0005.9%$13,500,000
2027Giants$13,200,000$4,000,000$500,000$100,000$0$17,800,0005.7%$13,800,000
Total$38,034,602$15,699,204$1,500,000$300,000$17,958,593$55,474,980$55,533,804

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2021161079.3%30.6%47212.5243710200200
2022170098.7%23.8%76171.57.5117201000
2023125064.1%12.1%512200304103100
2024150280.3%0.5%4220112224001000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$2,199,000$15,100,000
Injury Adjusted$2,199,000$15,100,000
test
OTC Valuation $2.9M $5.8M $8.7M $11.6M $14.5M APY $3.5M $7M $10.5M $14M $17.5M $4,388,000 $4,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.